Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328119934> ?p ?o ?g. }
- W4328119934 endingPage "5894" @default.
- W4328119934 startingPage "5894" @default.
- W4328119934 abstract "Uveal melanoma (UM) is the most common primary cancer of the eye in adults. A new systemic therapy is needed to reduce the high metastasis and mortality rate. As β-blockers are known to have anti-tumor effects on various cancer entities, this study focuses on investigating the effect of β1-selective blockers atenolol, celiprolol, bisoprolol, metoprolol, esmolol, betaxolol, and in particular, nebivolol on UM. The study was performed on 3D tumor spheroids as well as 2D cell cultures, testing tumor viability, morphological changes, long-term survival, and apoptosis. Flow cytometry revealed the presence of all three β-adrenoceptors with a dominance of β2-receptors on cell surfaces. Among the blockers tested, solely nebivolol concentration-dependently decreased viability and altered 3D tumor spheroid structure. Nebivolol blocked the repopulation of cells spreading from 3D tumor spheroids, indicating a tumor control potential at a concentration of ≥20 µM. Mechanistically, nebivolol induced ATP depletion and caspase-3/7 activity, indicating that mitochondria-dependent signaling is involved. D-nebivolol or nebivolol combined with the β2-antagonist ICI 118.551 displayed the highest anti-tumor effects, suggesting a contribution of both β1- and β2-receptors. Thus, the present study reveals the tumor control potential of nebivolol in UM, which may offer a perspective for co-adjuvant therapy to reduce recurrence or metastasis." @default.
- W4328119934 created "2023-03-22" @default.
- W4328119934 creator A5010019842 @default.
- W4328119934 creator A5031659840 @default.
- W4328119934 creator A5049061460 @default.
- W4328119934 creator A5061494282 @default.
- W4328119934 creator A5074461515 @default.
- W4328119934 creator A5076786068 @default.
- W4328119934 creator A5079417201 @default.
- W4328119934 creator A5080439557 @default.
- W4328119934 date "2023-03-20" @default.
- W4328119934 modified "2023-10-14" @default.
- W4328119934 title "Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures" @default.
- W4328119934 cites W145439482 @default.
- W4328119934 cites W1487341279 @default.
- W4328119934 cites W1736884335 @default.
- W4328119934 cites W1880913451 @default.
- W4328119934 cites W1975465206 @default.
- W4328119934 cites W1975679429 @default.
- W4328119934 cites W1981684516 @default.
- W4328119934 cites W1988280154 @default.
- W4328119934 cites W1994682335 @default.
- W4328119934 cites W2006851144 @default.
- W4328119934 cites W2012863869 @default.
- W4328119934 cites W2023093713 @default.
- W4328119934 cites W2024207854 @default.
- W4328119934 cites W2040429923 @default.
- W4328119934 cites W2055835855 @default.
- W4328119934 cites W2057802075 @default.
- W4328119934 cites W2069357664 @default.
- W4328119934 cites W2077517114 @default.
- W4328119934 cites W2086590249 @default.
- W4328119934 cites W2093148351 @default.
- W4328119934 cites W2102483598 @default.
- W4328119934 cites W2111505005 @default.
- W4328119934 cites W2136578530 @default.
- W4328119934 cites W2140723257 @default.
- W4328119934 cites W2141382054 @default.
- W4328119934 cites W2150740158 @default.
- W4328119934 cites W2157999078 @default.
- W4328119934 cites W2162358892 @default.
- W4328119934 cites W2167003284 @default.
- W4328119934 cites W2169729757 @default.
- W4328119934 cites W2257419316 @default.
- W4328119934 cites W2300492004 @default.
- W4328119934 cites W2406816853 @default.
- W4328119934 cites W2559127842 @default.
- W4328119934 cites W2570152363 @default.
- W4328119934 cites W2608308118 @default.
- W4328119934 cites W2896002881 @default.
- W4328119934 cites W2896312472 @default.
- W4328119934 cites W2901432051 @default.
- W4328119934 cites W2950989394 @default.
- W4328119934 cites W2955093231 @default.
- W4328119934 cites W2969077457 @default.
- W4328119934 cites W2979420081 @default.
- W4328119934 cites W2991695165 @default.
- W4328119934 cites W3021519969 @default.
- W4328119934 cites W3043495494 @default.
- W4328119934 cites W3093671550 @default.
- W4328119934 cites W3174545139 @default.
- W4328119934 cites W3177210510 @default.
- W4328119934 cites W3196128326 @default.
- W4328119934 cites W3198683701 @default.
- W4328119934 cites W3202104588 @default.
- W4328119934 cites W3205685501 @default.
- W4328119934 cites W3211945524 @default.
- W4328119934 cites W4200098350 @default.
- W4328119934 cites W4206773095 @default.
- W4328119934 cites W4214880118 @default.
- W4328119934 cites W4239072443 @default.
- W4328119934 cites W4281775272 @default.
- W4328119934 cites W4283367111 @default.
- W4328119934 cites W4311619483 @default.
- W4328119934 cites W910021339 @default.
- W4328119934 cites W910768158 @default.
- W4328119934 doi "https://doi.org/10.3390/ijms24065894" @default.
- W4328119934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36982966" @default.
- W4328119934 hasPublicationYear "2023" @default.
- W4328119934 type Work @default.
- W4328119934 citedByCount "0" @default.
- W4328119934 crossrefType "journal-article" @default.
- W4328119934 hasAuthorship W4328119934A5010019842 @default.
- W4328119934 hasAuthorship W4328119934A5031659840 @default.
- W4328119934 hasAuthorship W4328119934A5049061460 @default.
- W4328119934 hasAuthorship W4328119934A5061494282 @default.
- W4328119934 hasAuthorship W4328119934A5074461515 @default.
- W4328119934 hasAuthorship W4328119934A5076786068 @default.
- W4328119934 hasAuthorship W4328119934A5079417201 @default.
- W4328119934 hasAuthorship W4328119934A5080439557 @default.
- W4328119934 hasBestOaLocation W43281199341 @default.
- W4328119934 hasConcept C121608353 @default.
- W4328119934 hasConcept C126322002 @default.
- W4328119934 hasConcept C185592680 @default.
- W4328119934 hasConcept C190283241 @default.
- W4328119934 hasConcept C2777537511 @default.
- W4328119934 hasConcept C2777658100 @default.
- W4328119934 hasConcept C2778198053 @default.